Related Experiment Videos
Image analysis using the fluorochromasia assay to quantify tumor drug sensitivity
John F Gibbs1, Youcef M Rustum, Harry K Slocum
1Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA.
Methods in Molecular Medicine
|May 20, 2005
Summary
This study introduces a novel fluorescence imaging technique to rapidly assess drug effects on tumor cells. This method accurately measures tissue chemosensitivity, aiding in predicting patient response to cancer therapies.
Area of Science:
- Biomedical imaging
- Cancer research
- Drug discovery
Background:
- Assessing chemosensitivity is crucial for effective cancer therapy.
- Current methods can be slow and lack quantitative precision.
Purpose of the Study:
- To develop and validate a rapid, quantitative method for assessing tissue chemosensitivity.
- To evaluate the efficacy of a novel topoisomerase II inhibitor (NC-190) in human tumors.
Main Methods:
- Utilized fluorescence microscopy and image analysis to measure tissue fluorescence and tumor area.
- Employed a rodent model for serial measurements of tumor metabolic activity and growth.
- Applied the technique to fresh human tumors treated with NC-190.
Main Results:
- The system quantitatively measured changes in tumor metabolic activity and proliferative capacity.
- Fifty-five percent of human tumors demonstrated sensitivity to NC-190 after 48-hour exposure.
- The technique showed potential for serial assessment of tumor response.
Conclusions:
- Fluorescence imaging provides a rapid and quantitative assessment of tissue chemosensitivity.
- This method can serve as a valuable tool for preclinical drug evaluation and clinical therapy prediction.